[Bacteriologic management of patients with decreased resistance].
D000380:Agranulocytosis / Q000276:immunology*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000985:Antisepsis; D001424:Bacterial Infections / Q000517:prevention & control; D004338:Drug Combinations / Q000008:administration & dosage; D006801:Humans; D007165:Immunosuppression Therapy; D017053:Infection Control; D007239:Infections / Q000276:immunology; D009181:Mycoses / Q000517:prevention & control; D009268:Nalidixic Acid / Q000008:administration & dosage; D010272:Parasitic Diseases / Q000517:prevention & control; D010356:Patient Isolation; D013420:Sulfamethoxazole / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014777:Virus Diseases / Q000517:prevention & control
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D009268:Nalidixic Acid; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole
Bacteriologische begeleiding van patiënten met verminderde weerstand.